The 1st
supplement to the 9th edition of the European Pharmacopeia became
effective on 1st April 2017.
Of interest to readers:
Water for injections (0169)
Production: revision to
include purification processes equivalent to distillation (such as reverse
osmosis coupled with appropriate techniques) for producing water for injections
(WFI), in addition to distillation; use of non-distillation technologies for the
production of WFI requires that notice is given to the supervisory authority of
the manufacturer before implementation.
Posted by Dr. Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources